NCT06463938 A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH
| NCT ID | NCT06463938 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dow University of Health Sciences |
| Condition | Dentin Sensitivity |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-05-12 |
| Primary Completion | 2024-08-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-05-12 with a primary completion date of 2024-08-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).
Eligibility Criteria
Inclusion criteria: * Patients of either gender, with ages between 25-65 years * should have at least more than one hypersensitive and vital tooth without any carious lesion or defective restoration Exclusion criteria: * History of desensitizing therapy on the affected tooth/teeth in last six months (use of desensitizing toothpaste) * use of antibiotics /analgesic/anti-inflammatory drugs * history of smoking * pregnancy * those who are not willing to participate or give follow-ups
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06463938 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying Dentin Sensitivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06463938 currently recruiting?
Yes, NCT06463938 is actively recruiting participants. Contact the research team at sanam.faheem@duhs.edu.pk for enrollment information.
Where is the NCT06463938 trial being conducted?
This trial is being conducted at Karachi, Pakistan.
Who is sponsoring the NCT06463938 clinical trial?
NCT06463938 is sponsored by Dow University of Health Sciences. The trial plans to enroll 120 participants.